Elevated MiR-222-3p Promotes Proliferation and Invasion of Endometrial Carcinoma via Targeting ERα
出版年份 2014 全文链接
标题
Elevated MiR-222-3p Promotes Proliferation and Invasion of Endometrial Carcinoma via Targeting ERα
作者
关键词
MicroRNAs, Transfection, Estrogens, Cell proliferation, Metastasis, Mouse models, Apoptosis, Cancer treatment
出版物
PLoS One
Volume 9, Issue 1, Pages e87563
出版商
Public Library of Science (PLoS)
发表日期
2014-02-01
DOI
10.1371/journal.pone.0087563
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Estrogen and Cancer
- (2012) Jing Liang et al. Annual Review of Physiology
- High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma
- (2012) Chunzhi Zhang et al. Journal of Translational Medicine
- Markers for individualised therapy in endometrial carcinoma
- (2012) Helga B Salvesen et al. LANCET ONCOLOGY
- microRNA-222 Targeting PTEN Promotes Neurite Outgrowth from Adult Dorsal Root Ganglion Neurons following Sciatic Nerve Transection
- (2012) Songlin Zhou et al. PLoS One
- MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma
- (2011) Kai Sun et al. ACTA PHARMACOLOGICA SINICA
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Emerging therapeutic targets in endometrial cancer
- (2011) Konstantin J. Dedes et al. Nature Reviews Clinical Oncology
- microRNA and Cancer
- (2010) Mengfeng Li et al. AAPS Journal
- Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer
- (2010) Yingchun Zhao et al. BREAST CANCER RESEARCH AND TREATMENT
- An estrogen receptor α suppressor, microRNA-22, is downregulated in estrogen receptor α-positive human breast cancer cell lines and clinical samples
- (2010) Jianhua Xiong et al. FEBS Journal
- The association between metabolic abnormality and endometrial cancer: A large case-control study in China
- (2010) Yan Zhang et al. GYNECOLOGIC ONCOLOGY
- MicroRNA Cluster 221-222 and Estrogen Receptor α Interactions in Breast Cancer
- (2010) Gianpiero Di Leva et al. JNCI-Journal of the National Cancer Institute
- Endometrioid carcinoma of the endometrium: pathologic and molecular features
- (2010) Ainara Azueta et al. SEMINARS IN DIAGNOSTIC PATHOLOGY
- miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
- (2009) Michela Garofalo et al. CANCER CELL
- Revised FIGO staging for carcinoma of the endometrium
- (2009) William Creasman INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- miR-22 Inhibits Estrogen Signaling by Directly Targeting the Estrogen Receptor mRNA
- (2009) D. P. Pandey et al. MOLECULAR AND CELLULAR BIOLOGY
- Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines
- (2009) S-K Leivonen et al. ONCOGENE
- GATA3 expression in estrogen receptor α-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival
- (2008) Ingeborg B. Engelsen et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- The Promyelocytic Leukemia Zinc Finger-MicroRNA-221/-222 Pathway Controls Melanoma Progression through Multiple Oncogenic Mechanisms
- (2008) F. Felicetti et al. CANCER RESEARCH
- Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer
- (2008) Vincent Jongen et al. GYNECOLOGIC ONCOLOGY
- MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer
- (2008) Jian-Jun Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ESR1amplification in endometrial carcinomas: hope or hyperbole?
- (2008) DSP Tan et al. JOURNAL OF PATHOLOGY
- Activated Akt as an indicator of prognosis in gastric cancer
- (2008) Caterina Cinti et al. VIRCHOWS ARCHIV
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started